The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Women’s triple-negative, first-line treatment: Improving outcomes in triple-negative breast cancer (TNBC) using molecular triaging and diagnostic imaging to guide neoadjuvant therapy (NACT).
 
Stacy L. Moulder
Research Funding - Genentech (Inst); Oncothyreon (Inst); Pfizer (Inst)
 
Naoto T. Ueno
No Relationships to Disclose
 
Wei Tse Yang
No Relationships to Disclose
 
Joe Ensor
Consulting or Advisory Role - Aetna
 
Vicente Valero
No Relationships to Disclose
 
Jennifer Keating Litton
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Biomarin; Novartis
 
Rashmi Krishna Murthy
Research Funding - Oncothyreon (Inst)
 
Nuhad K. Ibrahim
No Relationships to Disclose
 
Banu Arun
Research Funding - Avon Foundation; NCI; NCI, Susan G. Komen, Avon; Susan G. Komen for the Cure
 
Elizabeth Ann Mittendorf
Honoraria - Galena Biopharma
Research Funding - Antigen Express (Inst); Galena Biopharma (Inst)
 
Kelly Hunt
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical
 
Alastair Mark Thompson
No Relationships to Disclose
 
Helen Piwnica-Worms
No Relationships to Disclose
 
Debu Tripathy
No Relationships to Disclose
 
William Fraser Symmans
Stock and Other Ownership Interests - Amgen; ISIS Pharmaceuticals; Nuvera Biosciences
Honoraria - Orlando Health
Patents, Royalties, Other Intellectual Property - Intellectual Property
Travel, Accommodations, Expenses - Affymetrix